JW Pharmaceutical Corp (001067) — Financial Flexibility Index
JW Pharmaceutical Corp (001067) has a Financial Flexibility Index of 0.22x as of September 2025. Free cash flow of ₩56.71 Billion (operating CF ₩46.92 Billion minus capex ₩9.80 Billion) represents 0% of total liabilities (₩257.46 Billion). Check JW Pharmaceutical Corp total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
JW Pharmaceutical Corp Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for JW Pharmaceutical Corp across 11 annual periods. For the full cash flow conversion analysis, see JW Pharmaceutical Corp (001067) cash conversion ratio.
Annual Financial Flexibility Index for JW Pharmaceutical Corp (2014–2024)
Year-by-year free cash flow to debt coverage for JW Pharmaceutical Corp. Explore 001067 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.39x | ₩107.53 Billion | ₩79.39 Billion | ₩275.11 Billion | ▲ +16.0% |
| 2023 | 0.34x | ₩127.86 Billion | ₩87.16 Billion | ₩379.60 Billion | ▲ +103.2% |
| 2022 | 0.17x | ₩66.68 Billion | ₩56.76 Billion | ₩402.21 Billion | ▲ +188.0% |
| 2021 | 0.06x | ₩25.59 Billion | ₩18.12 Billion | ₩444.51 Billion | ▼ -73.9% |
| 2020 | 0.22x | ₩75.44 Billion | ₩63.05 Billion | ₩341.62 Billion | ▲ +16.9% |
| 2019 | 0.19x | ₩64.82 Billion | ₩55.53 Billion | ₩343.12 Billion | ▲ +3.8% |
| 2018 | 0.18x | ₩60.75 Billion | ₩52.11 Billion | ₩333.68 Billion | ▲ +60.1% |
| 2017 | 0.11x | ₩40.95 Billion | ₩33.45 Billion | ₩360.10 Billion | ▲ +154.3% |
| 2016 | 0.04x | ₩16.76 Billion | ₩6.74 Billion | ₩374.76 Billion | ▲ +1156.3% |
| 2015 | 0.00x | ₩1.38 Billion | ₩-4.17 Billion | ₩388.07 Billion | ▼ -90.7% |
| 2014 | 0.04x | ₩14.21 Billion | ₩7.28 Billion | ₩369.22 Billion | — |